Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
Inactive Indication- |
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
通络救脑注射液治疗中风病(风火上扰、瘀血阻络证)安全性和有效性的随机、盲法、阳性药物对照的临床研究
[Translation] A randomized, blinded, positive drug-controlled clinical study on the safety and efficacy of Tongluo Jiunao Injection in the treatment of stroke (wind-fire disturbance, blood stasis blocking the collaterals syndrome)
通过Ⅱb期临床试验,对通络救脑注射液治疗脑梗塞急性期、中风病中经络(风火上扰、瘀血阻络证)的安全性和有效性做出进一步评价。
[Translation] Through Phase IIb clinical trials, the safety and effectiveness of Tongluo Jiunao Injection in treating the acute phase of cerebral infarction and meridian disorders in stroke (wind-fire disturbance, blood stasis blocking the meridians) were further evaluated.
100 Clinical Results associated with Inner Mongolia Kangyuan Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Inner Mongolia Kangyuan Pharmaceutical Co., Ltd.
100 Deals associated with Inner Mongolia Kangyuan Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Inner Mongolia Kangyuan Pharmaceutical Co., Ltd.